rAAV2-ND4
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for rAAV2-ND4, covering 2016-05-02 to 2020-09-17. Get the full timeline:
Most recent: Clinical Trial Update: A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy [Phase 2, Phase 3]